| Literature DB >> 28187184 |
Siriwan Boonma1, Adisak Romsang1, Jintana Duang-Nkern2, Sopapan Atichartpongkul2, Wachareeporn Trinachartvanit3, Paiboon Vattanaviboon2,4,5, Skorn Mongkolsuk1,2,4,6.
Abstract
Pseudomonas aeruginosa has two genes encoding ferredoxin NADP(+) reductases, denoted fprA and fprB. We show here that P. aeruginosa fprA is an essential gene. However, the ΔfprA mutant could only be successfully constructed in PAO1 strains containing an extra copy of fprA on a mini-Tn7 vector integrated into the chromosome or carrying it on a temperature-sensitive plasmid. The strain containing an extra copy of the ferredoxin gene (fdx1) could suppress the essentiality of FprA. Other ferredoxin genes could not suppress the requirement for FprA, suggesting that Fdx1 mediates the essentiality of FprA. The expression of fprA was highly induced in response to treatments with a superoxide generator, paraquat, or sodium hypochlorite (NaOCl). The induction of fprA by these treatments depended on FinR, a LysR-family transcription regulator. In vivo and in vitro analysis suggested that oxidized FinR acted as a transcriptional activator of fprA expression by binding to its regulatory box, located 20 bases upstream of the fprA -35 promoter motif. This location of the FinR box also placed it between the -35 and -10 motifs of the finR promoter, where the reduced regulator functions as a repressor. Under uninduced conditions, binding of FinR repressed its own transcription but had no effect on fprA expression. Exposure to paraquat or NaOCl converted FinR to a transcriptional activator, leading to the expression of both fprA and finR. The ΔfinR mutant showed an increased paraquat sensitivity phenotype and attenuated virulence in the Drosophila melanogaster host model. These phenotypes could be complemented by high expression of fprA, indicating that the observed phenotypes of the ΔfinR mutant arose from the inability to up-regulate fprA expression. In addition, increased expression of fprB was unable to rescue essentiality of fprA or the superoxide-sensitive phenotype of the ΔfinR mutant, suggesting distinct mechanisms of the FprA and FprB enzymes.Entities:
Mesh:
Substances:
Year: 2017 PMID: 28187184 PMCID: PMC5302815 DOI: 10.1371/journal.pone.0172071
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Efficiency of fprA deletion in P. aeruginosa strains carrying an extra copy of various genes.
| Efficiency of | |
|---|---|
| PAO1::Tn7T | ND |
| PAO1::Tn7T- | ND |
| PAO1::Tn7T- | 1.6 × 102 |
| PAO1::Tn7T- | ND |
| PAO1::Tn7T- | 2.1 × 101 |
| PAO1::Tn7T- | ND |
| PAO1::Tn7T- | ND |
| PAO1::Tn7T- | ND |
a Indicated strains of PAO1 were transformed with 1 μg pΔfprA::Gmr plasmid using electroporation. The transformants with fprA deletion were selected by the Gmr and Cbs phenotypes. The efficiency of fprA deletion is defined as the number of ΔfprA mutant obtained per 1 μg pUCΔfprA::Gmr plasmid. The data shown are means from triple independent experiments. ND, not detectable.
Fig 1fprA is an essential gene in P. aeruginosa.
The viability of exponential-phase cultures of P. aeruginosa PAO1 and ΔfprA mutant strains harboring an extra copy of fprA or fdx1 was determined using viable cell count on LB agar plates incubated at either 30°C or 45°C. The viability is expressed as a percentage of the CFU of the tested strain over the CFU of the PAO1::Tn7T or PAO1/pTS control.
Fig 2Expression analysis finR and fprA in response to various stresses.
The expression levels of finR (A) and fprA (B) were determined using real-time RT-PCR. Exponential-phase cultures of P. aeruginosa PAO1 were subjected to various stress conditions, including 1 mM H2O2, superoxide anion-generating agents (0.5 mM plumbagin [PB], 0.5 mM menadione [MD] and 0.5 paraquat [PQ]), organic hydroperoxides (1 mM cumene hydroperoxide [CHP] and 1 mM t-butyl hydroperoxide [tBH]), 1 mM 2,2’-dipyridyl (DIPY), high salts (0.5 M NaCl and 0.5 M KCl), or 0.04% NaOCl for 15 minutes prior to RNA preparation for real-time RT-PCR analysis. Relative expression was analyzed using the 16S rRNA gene as the normalizing gene and was expressed as the fold expression relative to the level of uninduced (UN) PAO1. Data shown are means ± SD of three independent experiments.
Fig 3Expression analysis of fprA and finR in P. aeruginosa strains.
Expression levels of fprA (A) and finR (B) in PAO1 wild type (PAO1::Tn7T), ΔfinR mutant (ΔfinR::Tn7T) and the complemented mutant (ΔfinR::Tn7T-finR) grown under uninduced, 0.5 mM paraquat (PQ), or 0.04% NaOCl (NaOCl) induced conditions. Relative expression was analyzed using the 16S rRNA gene as the normalizing gene and is expressed as fold expression relative to the level of uninduced PAO1. Data shown are means ± SD of three independent experiments. The asterisks indicate statistically significant differences (p < 0.01) compared with the uninduced condition.
Fig 4Characterization and binding of purified FinR to the finR-fprA promoter.
(A) Nucleotide sequence showing the finR-fprA promoter structure. +1 indicates the transcriptional start site, and the bold sequences are the putative -35 and -10 promoter motifs. and are the translational start codons of FinR and FprA, respectively. The box shaded gray represents the proposed FinR binding site. (B), (C), and (D) Electrophoretic mobility shift assay using purified FinR. A 32P –labeled DNA fragment (B), mutagenized MU1 and MU2 fragments (C), or the promoter fragments (EBI61-62), with (EBI 61–70) and without (EBI 62–69) proposed FinR binding site (D) spanning the finR-fprA promoter was incubated with increasing amounts of FinR. BSA represents an unrelated protein (2.5 μg BSA). CP and UD signify the cold probe (100 ng unlabeled promoter fragment) and unrelated DNA (1 μg of pUC18 plasmid), respectively, that were added to the binding reaction mixture containing 100 nM FinR. F and B indicate free and bound probes, respectively.
Fig 5Determination of paraquat resistance levels in P. aeruginosa strains.
(A) Paraquat resistance levels in PAO1 containing the mnin-Tn7 vector control (PAO1::Tn7T, red) and ΔfinR mutants containing Tn7T (dotted green), Tn7T-finR (purple), Tn7T-fprA (dotted blue), Tn7T-fprB (yellow), or Tn7T-fdx1 (dotted black) were determined using plate sensitivity assays. (B) Paraquat (150 μM) resistance levels of P. aeruginosa strains were determined using LB with and without 1% (w/v) KNO3 supplementation and incubated under aerobic and anaerobic atmospheres. The survival is expressed as a percentage of the CFU on LB plates containing paraquat over the CFU on plates without paraquat. Data shown are means ± SD from three independent experiments.
Fig 6Virulence of P. aeruginosa strains.
The virulence of PAO1 containing the Tn7T vector control (PAO1::Tn7T) and ΔfinR mutants containing Tn7T, Tn7T-finR, Tn7T-fprA, Tn7T-fprB, or Tn7T-fdx1 were determined using the Drosophila melanogaster feeding method. The percent fly survival was scored after 18 hours of incubation. Data presented are means ± SD of three independent experiments. The asterisk indicates statistically significant difference (p < 0.01) compared with PAO1::Tn7T. LB represents feeding the flies with LB medium.
List of plasmids used in this study.
| Plasmid | Relevant characteristic(s) | Source or Reference |
|---|---|---|
| pBBR1MCS-4 | Broad-host-range expression vector, Apr | [ |
| pSS255 | Expression vector with a temperature sensitive replicon (mSF | [ |
| pTS | pBBR1MCS-4 carrying mSF | This study |
| pTS- | pTS carrying | This study |
| pTS- | pTS carrying | This study |
| pTS- | pTS carrying | This study |
| pTS- | pTS carrying | This study |
| pTS- | pTS carrying | This study |
| pTS- | pTS carrying | This study |
| pUCΔ | pUC18 containing Gmr inserted into deleted | This study |
| pUCΔ | pUC18 containing Gmr inserted into deleted | This study |
| pCM351 | vector containing the | [ |
| pCM157 | vector containing the Cre-encoding gene, Tetr | [ |
| pUC18-mini-Tn7T::Gm-LAC | mini-Tn7 vector with Ptac expression cassette, Gmr | [ |
| pTNS2 | Helper plasmid for Tn7 insertion, Apr | [ |
| pTn- | pUC18-mini-TN7T::Gm-LAC containing | This study |
| pTn- | pUC18-mini-TN7T::Gm-LAC containing | This study |
| pTn- | pUC18-mini-TN7T::Gm-LAC containing | This study |
| pTn- | pUC18-mini-TN7T::Gm-LAC containing | This study |
| pTn- | pUC18-mini-TN7T::Gm-LAC containing | This study |
| pTn- | pUC18-mini-TN7T::Gm-LAC containing | This study |
| pTn- | pUC18-mini-TN7T::Gm-LAC containing | This study |
| pP | pUC18 carrying | This study |
| pP | pUC18 carrying mutagenized | This study |
| pP | pUC18 carrying mutagenized | This study |
| pQE30Xa | Vector for expressing N-terminal 6His tagged protein in | Qiagen (Germany) |
| pQE30Xa- | pQE30XA carrying full-length | This study |
Gmr, gentamicin resistance; Apr, ampicillin resistance; Tetr, tetracycline resistance; Cmr chloramphenicol resistance.
List of primers used in this study.
| BT2781 | Forward primer for 16S rRNA | |
| BT2782 | Reverse primer for 16S rRNA | |
| BT3332 | Forward primer for full-length | |
| BT3333 | Reverse primer for full-length | |
| BT3334 | Forward primer for | |
| BT3335 | Reverse primer for | |
| BT3336 | Forward primer for full-length | |
| BT3337 | Reverse primer for full-length | |
| BT3456 | Forward primer for | |
| BT3457 | Reverse primer for | |
| BT4443 | Forward primer for full-length | |
| BT4444 | Reverse primer for full-length | |
| BT4479 | Sp2 primer for | |
| BT4780 | Forward primer for mutated | |
| BT4781 | Reverse primer for mutated | |
| BT4782 | Forward primer for mutated | |
| BT4783 | Reverse primer for mutated | |
| BT3499 | Forward primer for full-length | |
| BT3500 | Reverse primer for full-length | |
| BT5019 | Sp1 primer for | |
| BT5201 | Forward primer for full-length | |
| BT5309 | Reverse primer for full-length | |
| EBI01 | Forward primer for full-length | |
| EBI02 | Reverse primer for full-length | |
| EBI53 | Forward primer for upstream fragment of | |
| EBI54 | Reverse primer for upstream fragment of | |
| EBI57 | Forward primer for upstream fragment of | |
| EBI58 | Reverse primer for upstream fragment of | |
| EBI61 | Forward primer for | |
| EBI62 | Reverse primer for | |
| EBI69 | Forward primer for | |
| EBI70 | Reverse primer for | |
| EBI73 | Forward primer for downstream fragment of | |
| EBI74 | Reverse primer for downstream fragment of | |
| EBI75 | Forward primer for downstream fragment of | |
| EBI76 | Reverse primer for downstream fragment of | |
| EBI269 | Forward primer for full-length | |
| EBI270 | Reverse primer for full-length | |
| EBI292 | Reverse primer for FinR protein expression | |
| EBI322 | Forward primer for FinR protein expression |